Journals
Publish with us
Publishing partnerships
About us
Blog
Sarcoma
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Sarcoma
/
2013
/
Article
/
Fig 1
/
Clinical Study
Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
Figure 1
Median PFS: 4.2 months (95% CI: 2.0–6.3). PFS rate at 1 year: 19.2%. Median followup: 6.7 months.